SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-19-000551
Filing Date
2019-08-12
Accepted
2019-08-12 20:47:34
Documents
1
Period of Report
2019-08-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8838
  Complete submission text file 0001012975-19-000551.txt   12197
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
CRANDELL KEITH (Reporting) CIK: 0001219039 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 191018041

Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
BYBEE CLINTON (Reporting) CIK: 0001219043 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 191018042

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 776-380-6600
ARCH Venture Fund VIII, L.P. (Reporting) CIK: 0001605598 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 191018045

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 7733806600
ARCH Venture Partners VIII, LLC (Reporting) CIK: 0001616165 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 191018043

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 7733806600
ARCH Venture Partners VIII, L.P. (Reporting) CIK: 0001616176 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 191018044

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)